tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Opus Genetics Inc

IRD
Add to Watchlist
2.865USD
-0.055-1.87%
Market hours （ET）Quotes delayed by 15 min
204.59MMarket Cap
LossP/E TTM

Opus Genetics Inc

2.865
-0.055-1.87%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

IRD Financials

See Opus Genetics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Opus Genetics Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.75/-0.14
Revenue / Forecast
2.16M/2.93M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
14.20M
29.15%
EPS(YoY)
-0.80
62.99%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-211.89%-0.75
82.28%-0.21
14.16%-0.25
61.06%-0.12
16.56%-0.24
-455.31%-1.16
-211.02%-0.29
-27.02%-0.30
-4.79%-0.29
-112.78%-0.21
--0.26
---0.24
---0.28
--1.63
----
----
----
----
----
----
Revenue
-50.64%2.16M
-10.16%3.87M
-20.38%3.08M
159.17%2.88M
155.41%4.37M
154.41%4.30M
-67.60%3.87M
-69.73%1.11M
-2.17%1.71M
-95.76%1.69M
--11.94M
--3.67M
--1.75M
--39.85M
-100.00%0.00
-100.00%0.00
----
--0.00
--489.00K
--100.00K
Net Profit
-699.79%-65.53M
52.97%-16.52M
-131.92%-17.45M
4.44%-7.42M
-15.31%-8.19M
-632.74%-35.13M
-235.34%-7.53M
-56.52%-7.76M
-22.71%-7.11M
-114.13%-4.79M
222.73%5.56M
-0.69%-4.96M
12.19%-5.79M
637.64%33.94M
-7.12%-4.53M
30.96%-4.93M
83.10%-6.59M
---6.31M
-201.39%-4.23M
-184.17%-7.14M
Net Margin
-1520.35%-3038.25%
47.66%-427.50%
-191.27%-566.87%
63.13%-257.46%
54.85%-187.51%
-188.02%-816.71%
-517.70%-194.62%
-417.14%-698.29%
-25.43%-415.31%
-432.93%-283.56%
--46.59%
---135.03%
---331.10%
--85.17%
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
--1.79%
--2.25%
--2.96%
--2.59%
----
----
----
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
Income Statement
Revenue
-50.64%2.16M
-10.16%3.87M
-20.38%3.08M
159.17%2.88M
155.41%4.37M
154.41%4.30M
-67.60%3.87M
-69.73%1.11M
-2.17%1.71M
-95.76%1.69M
--11.94M
--3.67M
--1.75M
--39.85M
-100.00%0.00
-100.00%0.00
----
--0.00
--489.00K
--100.00K
Operating profit
-57.34%-14.36M
-21.47%-11.45M
-0.03%-7.51M
-6.03%-8.41M
-30.27%-9.13M
-83.84%-9.43M
-214.01%-7.51M
-89.26%-7.93M
-20.19%-7.01M
-114.99%-5.13M
245.13%6.59M
15.17%-4.19M
10.40%-5.83M
656.26%34.21M
-7.23%-4.54M
30.81%-4.94M
-25.49%-6.51M
---6.15M
-181.03%-4.23M
-203.90%-7.14M
Net Profit
-699.79%-65.53M
52.97%-16.52M
-131.92%-17.45M
4.44%-7.42M
-15.31%-8.19M
-632.74%-35.13M
-235.34%-7.53M
-56.52%-7.76M
-22.71%-7.11M
-114.13%-4.79M
222.73%5.56M
-0.69%-4.96M
12.19%-5.79M
637.64%33.94M
-7.12%-4.53M
30.96%-4.93M
83.10%-6.59M
---6.31M
-201.39%-4.23M
-184.17%-7.14M
Balance Sheet
Current assets
38.96%66.60M
36.69%50.04M
-11.09%35.91M
-14.26%38.44M
-7.55%47.93M
-32.14%36.61M
-25.47%40.39M
3.16%44.83M
14.20%51.84M
10.13%53.95M
272.14%54.19M
142.92%43.46M
121.72%45.40M
87.92%48.99M
-37.22%14.56M
-29.12%17.89M
69.04%20.48M
47.54%26.07M
168.03%23.19M
151.73%25.24M
Total current liabilities
-61.49%9.34M
-31.11%7.78M
377.70%29.09M
380.99%20.19M
319.06%24.25M
179.44%11.29M
55.77%6.09M
-27.13%4.20M
39.31%5.79M
46.82%4.04M
45.26%3.91M
74.36%5.76M
29.29%4.15M
-28.59%2.75M
2.01%2.69M
22.42%3.30M
39.09%3.21M
21.04%3.85M
-12.33%2.64M
-9.34%2.70M
Total assets
38.66%66.79M
36.30%50.24M
-10.56%36.12M
-13.76%38.66M
-7.09%48.17M
-31.67%36.86M
-25.47%40.39M
3.15%44.83M
14.18%51.84M
10.12%53.95M
271.99%54.19M
142.83%43.47M
121.65%45.40M
87.87%48.99M
-37.22%14.57M
-29.12%17.90M
68.93%20.48M
47.48%26.08M
162.68%23.20M
146.38%25.25M
Total liabilities
262.41%87.89M
208.94%34.90M
395.24%30.16M
404.81%21.19M
319.06%24.25M
179.44%11.29M
55.77%6.09M
-27.13%4.20M
39.31%5.79M
46.82%4.04M
45.26%3.91M
74.36%5.76M
29.29%4.15M
-28.59%2.75M
2.01%2.69M
22.42%3.30M
39.09%3.21M
-87.62%3.85M
-15.44%2.64M
-16.85%2.70M
Total equity
-188.23%-21.10M
-39.97%15.35M
-82.60%5.97M
-57.00%17.47M
-48.07%23.92M
-48.77%25.57M
-31.78%34.30M
7.78%40.64M
11.65%46.06M
7.93%49.91M
323.36%50.28M
158.34%37.70M
138.83%41.25M
108.08%46.24M
-42.25%11.88M
-35.29%14.60M
75.96%17.27M
265.01%22.22M
259.92%20.57M
222.03%22.55M
Cash Flow Statement
Net operating income
-41.51%-12.73M
-32.20%-9.83M
-20.02%-6.16M
-40.83%-10.27M
-57.35%-8.99M
-263.54%-7.44M
-70.83%-5.13M
-837.31%-7.29M
-56.77%-5.72M
-84.20%4.55M
33.24%-3.00M
125.96%989.00K
40.91%-3.65M
609.94%28.79M
-25.50%-4.50M
11.99%-3.81M
-6.16%-6.17M
-112.50%-5.65M
-217.33%-3.58M
-141.90%-4.33M
Net investment
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--1.21M
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
100.00%0.00
--0.00
--0.00
--0.00
95.94%-100.00K
--0.00
--0.00
Net financing
34.84%27.59M
29146.99%24.11M
1186.97%4.54M
-41.17%906.00K
761.32%20.46M
-102.30%-83.00K
-93.43%353.00K
--1.54M
--2.38M
30125.00%3.60M
304.82%5.38M
-100.00%0.00
-100.00%0.00
-100.15%-12.00K
-17.00%1.33M
-91.16%1.59M
8720.00%882.00K
-61.98%8.03M
--1.60M
--17.96M

FAQs

What is the total revenue of Opus Genetics Inc?

According to Opus Genetics Inc's FY2025 earnings report, its total revenue reached 14.20M, with a year-on-year change of 10.99M.

What are the current assets of Opus Genetics Inc?

According to Opus Genetics Inc's FY2025 earnings report, its current assets were 50.04M, with a year-on-year change of 36.69.

What are the total assets of Opus Genetics Inc?

According to Opus Genetics Inc's FY2025 earnings report, its total assets of Opus Genetics Inc were 50.24M, with a year-on-year change of 36.30.

What are the total liabilities of Opus Genetics Inc?

According to Opus Genetics Inc's FY2025 earnings report, its total liabilities of Opus Genetics Inc were 34.90M, with a year-on-year change of 208.94.

What is the total equity of Opus Genetics Inc?

According to Opus Genetics Inc's FY2025 earnings report, its total equity of Opus Genetics Inc was 15.35M, with a year-on-year change of -39.97.

What is the net operating income of Opus Genetics Inc?

According to Opus Genetics Inc's FY2025 earnings report, its net operating income of Opus Genetics Inc was -36.50M, with a year-on-year change of -16.34.

What is the net financing of Opus Genetics Inc?

According to Opus Genetics Inc's FY2025 earnings report, its net financing of Opus Genetics Inc was 50.02M, with a year-on-year change of 1095.01.

What is the Earnings Per Share (EPS) of Opus Genetics Inc?

According to Opus Genetics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.80, with a year-on-year change of 62.99.

What is the net income of Opus Genetics Inc?

According to Opus Genetics Inc's FY2025 earnings report, its net income was -49.59M, with a year-on-year change of 13.80.

What is the net margin of Opus Genetics Inc?

According to Opus Genetics Inc's FY2025 earnings report, its net profit margin was -349.33, with a year-on-year change of 33.26.

What is the Return on Equity (ROE) of Opus Genetics Inc?

According to Opus Genetics Inc's FY2025 earnings report, its Return on Equity (ROE) was -449.36, with a year-on-year change of -121.16.

What is the Return on Assets (ROA) of Opus Genetics Inc?

According to Opus Genetics Inc's FY2025 earnings report, its Return on Assets (ROA) was -113.86, with a year-on-year change of 10.14.

What is the operating profit of Opus Genetics Inc?

According to Opus Genetics Inc's FY2025 earnings report, its operating profit was -36.50M, with a year-on-year change of -16.34.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy